13. Biological Therapies in Development for COPD

  1. Jan Lötvall
  1. J. Morjaria1 and
  2. R. Polosa2,3

Published Online: 29 FEB 2012

DOI: 10.1002/9781119998624.ch13

Advances in Combination Therapy for Asthma and COPD

Advances in Combination Therapy for Asthma and COPD

How to Cite

Morjaria, J. and Polosa, R. (2012) Biological Therapies in Development for COPD, in Advances in Combination Therapy for Asthma and COPD (ed J. Lötvall), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998624.ch13

Editor Information

  1. Krefting Research Centre, University of Gothenburg, Göteborg, Sweden

Author Information

  1. 1

    Department of Infection, Inflammation and Repair, University of Southampton, Southampton, UK

  2. 2

    Ospedale Santa Marta, U.O.C di Medicina Interna e Medicina d'Urgenza, Via, Gesualdo Clementi 36, 95124 Catania, Italy

  3. 3

    Dipartimento di Medicina Interna e Specialistica, Centro Antifumo Universitario, Università di Catania, Catania, Italy

Publication History

  1. Published Online: 29 FEB 2012
  2. Published Print: 3 FEB 2012

ISBN Information

Print ISBN: 9780470727027

Online ISBN: 9781119998624

SEARCH

Keywords:

  • biological therapies, in COPD;
  • persistent inflammatory response;
  • early stage, smoking cessation;
  • inflammatory infiltrate, in airways;
  • inflammatory cells, COPD pathogenesis;
  • CD8+ T-cells;
  • DCs and NK cells;
  • cytokines, chemokines in COPD;
  • chemokines, chemokine receptors

Summary

This chapter contains sections titled:

  • Introduction

  • Inflammatory cells involved in the pathogenesis of COPD

  • Cytokines and chemokines in COPD

  • Development of biological agents in COPD

  • Conclusions

  • References